Cinchona (Cinchona officinalis) — Hermetica Encyclopedia
Herbs (Global Traditional) · South American

Cinchona (Cinchona officinalis)

Provisional Strong Scorebotanical

Hermetica Superfood Encyclopedia

Evidence review status: unreviewed

Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.

Review flags: AWAITING_SEMANTIC_VALIDATION

Provisional Summary

Cinchona officinalis is a South American tree bark containing quinine alkaloids that block sodium channels and interfere with plasmodium parasites. The bark demonstrates antimalarial properties and potential antioxidant activity through its quinoline alkaloid content.

Screened PMID Records
Reported Benefits
Pending
Synergy Review
At a Glance
CategoryHerbs (Global Traditional)
GroupSouth American
Public Score StatusProvisional Strong
Primary Keywordcinchona benefits
Cinchona (Cinchona officinalis) — botanical
Cinchona (Cinchona officinalis) — botanical close-up

Origin & History

Cinchona (Cinchona officinalis) — origin
Natural habitat

Cinchona officinalis is a tree native to the Andean forests of South America, belonging to the Rubiaceae family, with its bark harvested as the primary medicinal source. The bark is dried and extracted using solvents like ethanol or water to isolate alkaloids, primarily through processes involving chromatography or solvent partitioning for purification.

Cinchona bark has been used for centuries in Peruvian and South American traditional medicine, primarily as an antimalarial febrifuge, and was adopted by Jesuits in the colonial period. Introduced to Europe in the 17th century as 'Peruvian bark' for treating malaria, it remains a flavor component in beverages today.Traditional Medicine

Research Narrative (Provisional)

The research dossier indicates a lack of specific human clinical trials, RCTs, or meta-analyses for Cinchona officinalis itself, with no PubMed PMIDs provided. Current evidence is primarily preclinical or historical, with modern uses for conditions like cancer, muscle cramps, or varicose veins lacking good scientific evidence from human trials.

Preparation & Dosage

Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.

Nutritional Profile

Cinchona bark (Cinchona officinalis) is not consumed as a conventional food source; its profile is dominated by bioactive alkaloids rather than macronutrients. Alkaloid content: Total alkaloids 3–15% dry weight of bark, with quinine comprising 3–7% dry weight (approximately 30–70 mg/g dried bark), quinidine 0.5–1.5% dry weight, cinchonine 0.5–1.0% dry weight, and cinchonidine 0.3–0.8% dry weight. Quinine bioavailability via oral ingestion is approximately 76–88% absorbed in the gastrointestinal tract, with peak plasma concentration reached in 1–3 hours. Polyphenolic compounds: Quinovic acid glycosides present at approximately 1–3% dry weight; tannins (primarily condensed tannins/proanthocyanidins) at 2–4% dry weight, contributing to the noted antioxidant activity (DPPH IC50 <50 μg/mL). Carbohydrates: Bark contains structural polysaccharides (cellulose, hemicellulose) comprising approximately 40–50% dry weight, but these are not bioavailable for nutrition. Quinovin (a bitter glycoside) present at trace levels (~0.5% dry weight). Minerals: Limited data; bark material contains trace calcium (~200–400 mg/100g dry weight estimated), potassium (~150–300 mg/100g), and magnesium (~50–100 mg/100g), though these are not nutritionally relevant at typical medicinal doses. Protein: Negligible (<2% dry weight). Fat: Negligible (<1% dry weight). Fiber: Not nutritionally applicable given non-food use. Volatile oils: Present at <0.5% dry weight. Note: Cinchona is used medicinally in very small doses (bark extracts, tinctures, tonic water trace amounts ~83 mg quinine/liter); it is not a dietary staple, and macronutrient data is largely irrelevant to its application.

Reported Mechanism (Provisional)

Mechanism of Action

Cinchona's primary bioactive compounds are quinine alkaloids that block voltage-gated sodium channels in cardiac and skeletal muscle. Quinine interferes with plasmodium parasite DNA replication and disrupts their food vacuole function. The bark's phenolic compounds contribute antioxidant activity through free radical scavenging mechanisms.

Clinical Narrative (Provisional)

Modern clinical evidence for cinchona is extremely limited, with most antimalarial research focusing on isolated quinine rather than whole bark extracts. Preclinical studies show antioxidant activity with DPPH IC50 values below 50 μg/mL in laboratory assays. Traditional use studies lack placebo controls and standardized dosing protocols. No recent randomized controlled trials have evaluated cinchona bark supplements for any health condition.

Also Known As

Cinchona officinalisPeruvian barkJesuit's barkQuinine barkFever treeRed cinchonaCascarillaChina bark

Explore the Full Encyclopedia

Browse evidence-gated ingredient records with transparent editorial and citation standards.

Browse Ingredients
These statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.
From the Hermetica Research Desk

Research updates — and 25% off your first order

Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.

Educational content only — not medical advice.